SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Citigroup Initiates Coverage On Arrowhead Pharmaceuticals with Buy Rating, Announces Price Target of $90

Citigroup analyst Shawn Egan initiates coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Buy rating and announces Price Target of $90.

· 11/19/2020 07:46
Citigroup analyst Shawn Egan initiates coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Buy rating and announces Price Target of $90.